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Summary Eighty-nine fresh tissue samples from flat colonic mucosa, polypoid lesions, macroscopically
evident carcinomas, and metastatic carcinomas from ten patients with longstanding ulcerative colitis () 8
years duration) were analysed by DNA flow cytometry and light microscopy. Of a total of ten carcinomas
found in six patients, six showed DNA aneuploidy. Three patients developed metastatic carcinomas, all with
aneuploid cell populations with similar DNA indices as in the primary carcinoma. Furthermore, aneuploid cell
populations with similar DNA indices often occurred, both in separate mucosa samples, as well as in mucosa
and carcinoma samples, from the same patient. DNA aneuploidy was found in flat mucosa in five of the six
patients with carcinoma, and in one of the four patients without carcinoma (P> 0.1). High grade dysplasia
was found in only four of the six cases with carcinoma, indicating that high grade dysplasia is insufficient as
marker for malignant development. DNA aneuploidy was found in 24% of the dysplastic mucosa samples,
and in 18% of the non-dysplastic mucosa samples (n.s., both with regard to high and low grade dysplasia).
Since abnormal DNA ploidy pattern was not confined to dysplastic epithelium only, DNA aneuploidy in flat
mucosa may constitute an additional marker in the identification of patients at increased cancer risk who
could benefit from a closer surveillance.
The management of patients with longstanding ulcerative
colitis is mainly based on surveillance for the development of
precancerous changes (Riddell, 1984). Several reports have
shown a close association between dysplastic changes in
tumour-distant flat mucosa and coexisting colorectal car-
cinoma in patients with total ulcerative colitis (Morson &
Pang, 1967; Riddell & Morson, 1979; Rosenstock et al.,
1985, Ransohoff et al., 1985). However, dysplasia alone
seems to be an insufficient marker for the optimal
identification of patients at increased cancer risk. Firstly, the
interpretation of dysplasia is subjective, and thus prone to a
substantial intraobserver and interobserver variation (Riddell
et al., 1983; Melville et al., 1988; Dixon et al., 1988).
Secondly, as dysplastic lesions may be distributed focally,
there is a problem of adequate sampling (Riddell, 1976;
Riddell & Morson, 1979; Ransohoff et al., 1985). Thirdly,
patients have developed carcinomas without having dysplasia
detected in advance or in the operative specimen (Riddell,
1976; Lennard-Jones et al., 1983). Better and more objective
markers of early malignant transformation in the colonic
epithelium are therefore clearly needed.
Abnormal cellular DNA content is generally considered to
be a marker of premalignancy (Barlogie et al., 1983). Flow
cytometric DNA analysis is a rapid, objective and reproduci-
ble method for the evaluation of cellular DNA aberrations.
Aneuploid cell populations have previously been found by
DNA flow cytometry in the colonic mucosa of patients with
ulcerative colitis, both preceding and coexistent with colonic
carcinomas. Diverging results have been reported, however,
both with regard to the proportion of aneuploid carcinomas
in patients with ulcerative colitis, as well as the relationship
between dysplasia and aneuploidy in tumour-distant flat
mucosa (Hammarberg et al., 1984, Fozard et al., 1986,
L0fberg et al., 1987, Melville et al., 1988, Fischbach et al.,
1990).
In the present study, we have analysed the DNA ploidy
pattern in flat mucosa, and in primary and metastatic car-
cinomas from patients with longstanding ulcerative colitis.
We have evaluated the relationship between aneuploidy and
dysplasia, and between aneuploidy and carcinoma, and com-
pared the DNA ploidy pattern in primary and metastatic
carcinomas. Based on the results from our DNA analysis, we
have also discussed the DNA ploidy changes emerging dur-
ing carcinogenesis in ulcerative colitis.
Patients, materials and methods
Patients
Ten patients with total ulcerative colitis for eight years or
more were studied. Nine patients underwent proctocol-
ectomy, and one patient hemicolectomy. Six patients had
proctocolectomy done because of histologically verified car-
cinomas, and one of these patients had two carcinomas
diagnosed preoperatively. Three additional carcinomas were
found in the resected specimens from two of these patients
(Table II). Two patients had synchronous, and one patient
had metachronous metastases (Table I). Four patients were
operated prophylactically due to dysplasia in biopsy samples
and/or increased disease activity (Table I). None of the latter
patients had carcinoma diagnosed in the resected specimens.
Clinicopathological information on the patients and their
carcinomas are given in Table I.
Tissue sampling
Eighty-nine fresh tissue samples from colonic flat mucosa,
polypoid lesions, macroscopically evident carcinomas, and
metastases were collected from resected specimens (including
one sample from the autopsy of patient no. 2) (Table II).
From the seven preoperatively recognised carcinomas, a
median of three (range 1 to 5) tissue samples were taken.
From flat mucosa (and from the three polypoid lesions in
patient no. 1), tissue samples were collected from a median of
six (range 3 to 11) random locations (Table II). All three
patients with disseminated disease had metastases analysed;
patient no. 1 had one retroperitoneal metastasis collected
during second-look surgery 24 months after proctocolectomy,
patient no. 2 had retroperitoneal cancer spread diagnosed at
the time of primary surgery, from which a sample was col-
lected during autopsy 5 months later, and patient no. 6 had a
liver metastasis collected peroperatively.
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Table I Clinicopathological information on ten patients with longstanding ulcerative colitis (UC)
Patient Duration of Indication Type of Site of Dukes' Histological Site of Surv. after
No. Age/Sex UC (years) for operat. operation main carcinoma stage" grade' metastasis prim. op. (mo)
I 30/M 13 Carcinoma Proctocolectomy Sigmoid C Mucinous Peritoneum 126
colon adenocarcinoma
2 35/M 18 Carcinoma Right hemicolectomy Caecum D Poorly Disseminatedc 5d
differentiated
3 32/F 9 Carcinoma Proctocolectomy I': Hepatic B Poorly None 127
flexure differentiated
Ile: Descending A Well
colon differentiated
4 36/M 13 Carcinoma Proctocolectomy Sigmoid A Moderately None 73
colon differentiated
5 34/M 19 Carcinoma Proctocolectomy Splenic B Mucinous None 26
flexure adenocarcinoma
6 39/M 12 Carcinoma Proctocolectomy Rectum D Poorly Liver Id
differentiated
7 37/M 20 Exacerbation Proctocolectomy
8 30/F 8 Exacerbation Proctocolectomy
and dysplasial
9 33/F 23 Dysplasia Proctocolectomy
10 37/M 21 Exacerbation Proctocolectomy
aAccording to the modified Dukes' classification (Dukes, 1932;Turnbull etal., 1967).bAccording to thecriteriagivenby WHO(Morson &Sobin,
1976). CPre- andperoperatively diagnosed metastasis in alymph node located on theneck, in theretroperitoneal tissue, and in the liver. dUntil death. eThis patient had two macroscopical evident carcinomas. 'In this patient, dysplasia could not be verified in the operative specimen.
Table II DNA-indices and degree ofdysplasia in tissue samples from ten patients with longstanding ulcerative colitis
Tissue Patient No.
sample 1 2 3 4 5 6 7 8 9 10
Macrosc. 1.5 1.3 IC: 1.0 1.0 1.0 A4/2.3d
evident (n= 5)a (n= 3) (n= 1) (n=2) (n= 2) (n=2)
carcinoma lO.b Ic: 1.0 2.3
(n = 1) (n = 1) (n = 3)
Flat 2.6 1.3 1.0 1.7 1.0 2.3 1.0 1.0 1.0 1.0
mucosa highe high high low no no low no high low
1.0 1.0 1.7 1.0 2.1 1.0 1.0 1.0 1.0
high low low high no low no high ind
1.0 1.0 1.7 1.7 1.0 1.0 1.0 1.0 1.0
high high ind no no low no ind ind
1.0 1.0 1.0 1.0 1.0 1.0 1.0
no low no low no low low
1.7 1.0 1.0 1.0 1.0 1.7 1.0
low low no low no no no
1.7 1.0 1.0 1.0 1.0 1.7 1.0
low low no low no no ind
1.7 1.0 1.0 1.0
ca low no no
1.7 1.0 1.0 1.0













Metastasis 1.5 1.3 2.1
(n = 2) (n = 1) (n =1)
aNumberofsamplesanalysedwiththesame DNAindex.bOnesample fromthiscarcinomashowedonlydiploidcells.cTwomacroscopicallyevident
carcinomas were found in this patient. dTwo samples from this carcinoma showed two aneuploid cell populations, with DNA indices of 1.4 and 2.3, respectively. eDenominators indicate grade ofdysplasia, high: high grade dysplasia; low: low grade dysplasia; ind: indefinite for dysplasia; no: no
dysplasia; ca: infiltrating growth (carcinoma).
Histological grading ofdysplasia
The histological grading of epithelial dysplasia was done on
hematoxylin-eosin stained sections adjacent to the samples
processed for DNA flow cytometry, and performed indepen-
dently by two pathologists. Whenever discrepancy existed in
classification, a joint diagnosis was achieved. The mucosa
samples were categorized into: no dysplasia, indefinite for
dysplasia, low grade or high grade dysplasia, according to
the latest standardised classification of dysplasia in
inflammatory bowel disease (Riddell et al., 1983).
DNAflow cytometry
Single cell suspensions were prepared immediately after sur-
gery (in one instance immediately after autopsy). The tissue
samples were minced in ice-cold phosphate-buffered salineDNA PLOIDY IN MUCOSA AND CARCINOMA OF UC 341
(PBS), pH 7.6, followed by nylon mesh filtration (mesh pore
size 70pm) (Seidengazefabrik AG Thal, Switzerland). The
cells were fixed and stored in 70% ethanol at 4°C until they
were further processed for DNA flow cytometry. The stain-
ing for DNA flow cytometry in patients nos. 1, 2 and 3 was
done with ethidium bromide (Calbiochem, California, USA)
according to the description by G6hde & Dittrich (1971).
Prior to the staining, the cells were treated with RNAase
(Boehring, Mannheim, Germany), 1 g 1-' in water, 1 h at
37°C, and pepsin (Orthana, Copenhagen, Denmark), 4 g ['
in 0.02 N HCI, 15 min at 37°C. The measurements were
performed with an ICP 11 flow cytometer (Phywe AG, Got-
tingen, Germany). Tissue samples collected from patients nos.
four to ten were stained according to the method described by
by Crissman & Steinkamp (1982). The cells were incubated
with RNAase (Boehring, Mannheim, Germany), 190 ygml-'
for 30 min in the dark at 20°C, and thereafter stained with
the fluorochrome propidium iodide (Sigma Chemical Co., St.
Louis, MO, USA), 171tgml-I for 1 h in the dark at 0°C. The
analyses were done with an Ortho Cytofluorograph 50H
(Ortho Instruments, Westwood, MA, USA).
Mouse spleen lymphocytes were used as an external dip-
loid (2c) DNA control. The cellular amount of DNA was
expressed as a DNA index (Hiddemann et al., 1984). A tissue
sample was defined as aneuploid when a second detectable
population ofGI cells was present with a DNA index > 1.10,
otherwise the tissue sample was defined as diploid (or in
samples from carcinomas, as near diploid).
Statistical analysis
For differences in distributions, the X2 test with Yates correc-
tion for small numbers was applied.
Results
DNA ploidy pattern in carcinomas and in tumour-distantflat
mucosa
Six of the ten carcinomas (60%) were aneuploid (Table II,
and Figures 1 and 2). The six aneuploid carcinomas were
found in patients nos. 1, 2, 4, and 6. These four patients also
had aneuploid cell populations in tumour-distant flat mu-
cosa. Three of these four patients (patients nos. 2, 4, and 6)
had the same DNA index in tumour-distant flat mucosa as in
(one of) the carcinoma(s). Two patients (patients nos. 3 and
5), had near diploid carcinomas. Patient no. 5 had aneuploid
cells in tumour-distant flat mucosa, whereas this was not
found in patient no. 3. In the three patients with two or more
carcinomas (patients nos. 1, 3, and 4) there was no consistent
DNA ploidy pattern between the different carcinomas within
the same patient (Table II, and Figures 1 and 2).
DNA ploidy pattern inflat mucosafrom patients without
carcinoma
Twenty-nine mucosa samples were analysed from the four
patients without carcinoma. Only two of these samples (from
patient no. 9) were aneuploid, both with a DNA index of 1.7
(Table II).
Relationship between DNA aneuploidy anddysplasia
Five of the six carcinoma patients, and one of the four
patients without carcinoma had DNA aneuploidy in flat
mucosa (P>0.1) (Table II). Epithelial dysplasia in flat
mucosa was found in five of the six carcinoma patients, and
three of the four patients without carcinoma (Table II). High
grade dysplasia was demonstrated in four of the six patients
with carcinoma, and in one of the four patients without
carcinoma.
From the six patients with carcinoma, 32 non-cancerous
flat mucosa samples were analysed (Table II). Eighteen sam-
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Figure 1 Flow cytometric DNA histograms of different cell
populations, and their corresponding locations in the colorectal
specimen from patient 1. This patient also had three polypoid
lesions of which the two closest to the main carcinoma are
indicated. The 2c peaks indicate the diploid cell population in
each tissue sample. a One of five similar DNA histograms from
the main carcinoma, demonstrating an aneuploid cell population
(AN) with DNA index of 1.5. b One aneuploid cell population
(AN) with DNA index of 1.4, from a cancerous polypoid lesion
next to the main carcinoma. c One aneuploid cell population
(AN) with DNA index of 2.1, from a cancerous polypoid lesion.
d One aneuploid cell population (AN) with DNA index of 2.6,
located in tumour-distant flat mucosa.
mucosa samples (39%) were aneuploid, compared with four
of 14 non-dysplastic mucosa samples (29%) (n.s.). Two of
the seven mucosa samples with high grade dysplasia (29%),
and five of the 11 mucosa samples with low grade dysplasia
(45%) were aneuploid, both compared with four of 14 non-
dysplastic mucosa samples (both n.s., respectively).
From the four non-carcinoma patients, a total of 29
mucosa samples were analysed. Eleven samples (38%) had
dysplastic changes, but none of these showed aneuploid cell
populations.
Of the total of 61 non-cancerous flat mucosa samples,
seven of 29 dysplastic mucosa samples (24%) were aneuploid,
compared with six of 32 non-dysplastic mucosa samples
(18%) (n.s.). Two of nine mucosa samples with high grade
dysplasia (22%), and five of 20 mucosa samples with low
grade dysplasia (25%) were aneuploid, both compared with
six of the 32 non-dysplastic mucosa samples (both n.s.,
respectively).
DNA ploidy pattern in primary and metastatic carcinoma
The six patients with carcinomas were followed postopera-
tively for 26 months or more (Table I). The three patients
with metastases all had aneuploid cell populations with the
same or similar DNA indices in the primary carcinoma as in
the metastatic lesions (Table II, Figure 3).
Discussion
The colonoscopic surveillance for premalignancy in patients
with ulcerative colitis is currently based on screening for
dysplastic changes in biopsy samples at repeated examina-
tions (Riddell, 1984). The grading of dysplasia, however, is




















Figure 2 Flow cytometric DNA histograms of different cell
populations, and their corresponding locations in patient 4. a
One of two similar DNA histograms from the main carcinoma,
demonstrating a near diploid cell population (2c). b The only
diploid cell population detected (of a total ofeight samples) from
tumour-distant flat mucosa. c One aneuploid cell population
(AN) with DNA index of 1.7, from flat mucosa which his-
tologically showed invasive growth. d One of six similar DNA
histograms demonstrating one aneuploid cell population (AN)
with DNA index of 1.7, from the six indicated locations (U)
from tumour-distant flat mucosa.
highly subjective (Riddell et al., 1983; Melville et al., 1988;
Dixon et al., 1988), and is further complicated if severe
inflammation is present (Riddell, 1976; 1983). Among other
markers of premalignancy (Rognum et al., 1987a) DNA
aneuploidy reflecting abnormal chromosome content within
cell nuclei, has become the one of greatest interest.
In the present study, aneuploid cell populations could be
demonstrated in six of ten colonic carcinomas from patients
with ulcerative colitis. We have earlier reported similar pro-
portions of aneuploidy in colorectal carcinomas from larger
series of patients without ulcerative colitis (Rognum et al.,
1982; 1987b; Meling et al., 1991). Other studies have also
reported similar proportions of aneuploid carcinomas in
patients with ulcerative colitis (Hammarberg et al., 1984;
Melville et al., 1988). In one study, however, a much lower
proportion of aneuploid carcinomas in ulcerative colitis was
found (Fozard et al., 1986), but a small number of samples
analysed from each carcinoma might perhaps explain the low
rate of aneuploidy detected (Rognum et al., 1980; Fozard et
al., 1987; Melville et al., 1987).
In the six patients with carcinoma, high grade dysplasia
was present only in four. This indicates that high grade
dysplasia is not sufficient as marker for malignant develop-
ment.
Dysplasia and DNA aneuploidy are different markers of
malignant cell transformation. The relationship between
them, however, is still not settled. Some studies have demon-
strated a significant association between the two markers
(Hammarberg et al., 1984; Melville et al., 1988), whereas in
other reports, no relationship was found (Fozard et al., 1986;
Fischbach et al., 1990). In the present study, we could dem-
onstrate no significant association between DNA ploidy pat-
tern and dysplasia. A part of this discrepancy may be due to
the fact that the assessment of dysplasia is highly subjective
compared with the more objective evaluation of DNA ploidy
J
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Figure 3 Flow cytometric DNA histograms from a the main
carcinoma, and b the retroperitoneal metastasis removed 24
months later from patient 1. a Shows one aneuploid cell popula-
tion from the main carcinoma with DNA index of 1.5. b Shows
one of two DNA histograms from the metastasis, demonstrating
one aneuploid cell population with DNA index of 1.5. In these
DNA analysis, both an old sample from the main carcinoma and
the freshly removed metastasis were analysed according to the
method of Crissman & Steinkamp (1982).
pattern (Melville et al., 1988). However, our results suggest
that in patients with ulcerative colitis, aneuploidy and dys-
plasia occur independently in the individual mucosa samples.
A close association has earlier been demonstrated between
the presence of carcinoma and aneuploidy in tumour-distant
flat mucosa (Hammarberg et al., 1984; Melville et al., 1988).
In our study, DNA aneuploidy was found in tumour-distant
flat mucosa in five of six patients with carcinoma, and in one
of four patients without carcinoma (this patient being the
one with high grade dysplasia among the non-carcinoma
patients). This indicates that DNA aneuploidy is associated
with malignant transformation in the large bowel, but larger
series is needed to evaluate the specificity of aneuploidy for
cancer development in ulcerative colitis mucosa. However,
since approximately one out of three large bowel carcinomas
are near diploid, the absence of aneuploidy in flat mucosa
does not exclude malignant transformation elsewhere in the
mucosa. We could, however, demonstrate that aneuploid cell
populations in tumour-distant flat mucosa were not restricted
to the patients with aneuploid carcinomas, since two of the
three patients with (microscopically evident) near diploid
carcinomas, had aneuploid cell populations in tumour-distant
flat mucosa (Figure 2).
In aneuploid adenomas, another premalignant lesion in the
colonic mucosa, a high percentage of DNA indices between
0.80 and 1.20 has been reported (van den Ingh et al., 1985;
Giaretti et al., 1988; Giaretti & Santi, 1990), although DNA
indices similar to those of adenocarcinomas have also been
reported (Quirke et al., 1986). This low ploidy alteration was
suggested to reflect early steps in the aneuploid transforma-
tion in the carcinogenesis of colorectal adenomas. In our
study, however, the high proportion of aneuploid cell clones
with a DNA index of 1.7 (present in nine of 14 aneuploid
mucosa samples) (Figure 2) indicates that this ploidy change
may be associated with early aneuploid malignancy in ulcer-
I 1.
1
AL. I..DNA PLOIDY IN MUCOSA AND CARCINOMA OF UC 343
ative colitis. The process of carcinogenesis may therefore be
different in adenomas and in ulcerative colitis mucosa. This is
further supported by a recent study of c-Ki-ras mutations,
reporting different genetic pathways for tumour progression
in colonic mucosa with and without ulcerative colitis (Burmer
et al., 1990). A combination of flow cytometric and genetic
analyses addressing this question are already in progress in
our laboratory.
Five patients had aneuploid carcinomas. Three of them
also had aneuploid cell clones in tumour-distant flat mucosa,
and these three were the only patients with metastatic disease
(Table II). This is, however, interesting, since aneuploid car-
cinomas are associated with a worse prognosis than diploid
ones (Wolley et al., 1982; Armitage et al., 1985; Rognum et
al., 1987b; 1991). The aneuploid cells in the mucosa from
these three patients, all had DNA indices different from 1.7,
and in two of the patients, the DNA index was the same as
in the main carcinoma. Furthermore, the DNA indices found
in the primary carcinomas of these three patients, were also
demonstrated in the metastatic carcinomas, respectively
(Rognum et al., 1985). The aneuploid cells found in the
mucosa of these patients may therefore have reached a point
in the carcinogenesis where the ploidy changes are preserved
in the cell population that grow invasively, and subsequently
establish distant organ metastases.
Within single patients, we frequently observed aneuploid
cell populations from separate mucosa samples with similar
DNA indices, (Table II, Figure 2) as has also been reported
by others (Fozard et al., 1986, Rutegard et al., 1989). We
also found the same DNA index in cells from mucosa- and
carcinoma samples within single patients. This individual
preference of certain ploidy changes might be the result of
evenly distributed carcinogenic factors in the colonic mucosa.
Furthermore, the genetic constitution of the patient is also
likely to influence the ploidy changes (Hsu, 1983). Aneuploid
cell clones with identical DNA indices have previously been
reported in synchronous carcinomas, supposed to reflect a
transluminal metastatic spread from a single lesion (Schwartz
et al., 1986). A transluminal spread is, however, highly
unlikely in our ulcerative colitis patients, since we found
similar DNA indices in separate premalignant lesions (which
do not have the potential to metastasise), and also in both
premalignant and malignant lesions.
Our results show that aneuploidy occurring in flat mucosa
ofpatients with ulcerative colitis is not confined to dysplastic
epithelium. DNA flow cytometric analysis may therefore con-
tribute, together with other markers (Rognum et al., 1987a),
to the identification of the subset of patients with increased
cancer risk, and who might therefore benefit from a closer
surveillance. Larger series of patients is however needed to
evaluate the specificity of aneuploidy occurring in ulcerative
colitis mucosa.
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